Gardner, B. Honer, L. Kopala, A. Labelle, Expert Canadian consensus suggestions on the rational, clinical use of ziprasidone in the treatment of schizophrenia and related psychotic disorders.A. Stroup, R.A. Rosenheck, J.A. The Consensus Study Group on Risperidone Dosing.S.J.

Schuck, H. van den Ameele, P. Jaanson, V. Ryckmans, C. Hawley.Case histories illustrating the utility of sertindole in clinical practice.L. This group of experts refined the draft in 2 subsequent teleconferences. J. W. Newcomer and D. W. Haupt, The metabolic effects of antipsychotic medications, Can. Among the atypical antipsychotics, as of December 2010, long-acting risperidone is available in Spain, and long-acting olanzapine will soon be available.Specific recommendations have been made for switching to long-acting risperidone (risperidone-LA), which are summarized belowMost patients receiving depot conventionals may be switched to risperidone-LA straight away.If patients have come off a non-depot antipsychotic, including the standard risperidone formulation, this drug should be continued for 3 weeks after initiating risperidone-LA therapy to ensure that the main release phase of risperidone from the injection site has begun. 12) (2003) 5-19.4.

Marcus, C. Breder, R.M.

Res.

Meltzer, L. Alphs, A.I.

Jones, T.R. Casey, W.H. Use of antipsychotics when breast-feeding 28 10.

Rummel-Kluge, K. Komossa, S. Schwarz, H. Hunger, F. Schmid, W. Kissling, Second-generation antipsychotic drugs and extrapyramidal side effects: a systematic review and meta-analysis of head-to-head comparisons.J.A.

Basson, J.A. J.

Asenjo Lobos, K. Komossa, C. Rummel-Kluge, H. Hunger, F. Schmid, S. Schwarz, Clozapine versus other atypical antipsychotics for schizophrenia.S.W. A. Lieberman, T. S. Stroup, J. P. McEvoy, M. S. Swartz, R. A. Rosenheck, D. O. Perkins, R. S. Keefe, S. M. Davis, B. D. Lebowitz, J.